
price close busi may
global leader diagnost breast
imag surgic product focu women
health also sell medic aesthet
diagnost tool
growth diagnost off-set anoth miss
impair charg cynosur reiter hold
deliv top line beat driven molecular diagnost penni bottom
line beat rais fy top bottom line guid proport beat
compani gener strong double-digit growth molecular diagnost
panther franchis off-set anoth miss cynosur news
compani took second larg impair charg busi time
lack convict cynosur remain part futur think
make sens divest reiter hold rais pt
rev rep fxn beat /street adj
ep beat our/street deliv beat diagnost
vs model explain beat off-set miss cynosur
rel street drove beat diagnost breast health
gyn/surg off-set miss cynosur adj om
miss larg relat dropdown declin
gross margin continu declin adj gm y/i miss
due on-going product mix geograph shift lower ou addit
drag major incur cynosur plu charg breast
health expect drag lift expect improv product mix
stop short call y/i growth gm year
breast health remain bright spot breast health rev beat
street y/i driven growth us
breast health growth ou fxn newer acquisit
faxitron ad rev addit help smartcurv paddl
breast stabil system perform dimens estim
place geniu unit us convert ib
cynosur miss impair cyno rev y/i miss
street driven declin bodi fat remov cite competit
weaker expect growth asia though us declin ou
announc today took anoth impair charg cynosur follow
initi impair charg indic process
put togeth longer term plan determin gaug spend divis
go forward indic oblig think object
busi believ would accret divest cynosur sinc unit dilut
top bottom line growth like multipl stock invest
clinic trial vitalia mona lisa touch mlt fund larg direct sale forc
appoint brook shield spokesperson
guidanc pure carri forward beat vs midpoint guid rais
revenue guid
report adj ep penni
guid street out-quart rev
flat vs prior adj ep
vs prior
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ object view
compani secur subject report discuss herein
import inform pleas see import disclosur begin page document
growth segment make formal comment prepar
remark call regard segment growth outlook howev
compani track ahead goal breast health molecular diagnost
track goal cynosur previous indic formal
comment expect gener low-to-mid singl digit revenu growth
segment except breast health segment target mid-
single-digit growth like breast health molecular diagnost hit
msd hsd growth cyno hit neg low-to-mid singl digit growth
year though possibl may come lower view
hold unchang target price may
diagnost tool
compani report canaccord genuiti estim detail financi model includ balanc sheet incom statement cash flow project avail may obtain contact canaccord genuiti sale person author analyst whose contact
inform appear front page report
hold unchang target price may
diagnost tool
hold unchang target price may
diagnost tool
